These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 30043162)

  • 1. Magnetic resonance elastography can predict development of hepatocellular carcinoma with longitudinally acquired two-point data.
    Ichikawa S; Motosugi U; Enomoto N; Onishi H
    Eur Radiol; 2019 Feb; 29(2):1013-1021. PubMed ID: 30043162
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liver stiffness measured by MR elastography is a predictor of early HCC recurrence after treatment.
    Cho HJ; Kim B; Kim HJ; Huh J; Kim JK; Lee JH; Seo CW; Ahn HR; Eun JW; Kim SS; Cho SW; Cheong JY
    Eur Radiol; 2020 Aug; 30(8):4182-4192. PubMed ID: 32189053
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic Role of Liver Stiffness Measurements Using Magnetic Resonance Elastography in Patients with Compensated Chronic Liver Disease.
    Lee DH; Lee JM; Chang W; Yoon JH; Kim YJ; Lee JH; Yu SJ; Han JK
    Eur Radiol; 2018 Aug; 28(8):3513-3521. PubMed ID: 29488082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk assessment of hepatocellular carcinoma development by magnetic resonance elastography in chronic hepatitis C patients who achieved sustained virological responses by direct-acting antivirals.
    Tamaki N; Higuchi M; Kurosaki M; Kirino S; Osawa L; Watakabe K; Wang W; Okada M; Shimizu T; Takaura K; Takada H; Kaneko S; Yasui Y; Tsuchiya K; Nakanishi H; Itakura J; Takahashi Y; Enomoto N; Izumi N
    J Viral Hepat; 2019 Jul; 26(7):893-899. PubMed ID: 30974045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liver stiffness in magnetic resonance elastography is prognostic for sorafenib-treated advanced hepatocellular carcinoma.
    Kim B; Kim SS; Cho SW; Cheong JY; Huh J; Kim JK; Lee JH; Ahn HR; Cho HJ
    Eur Radiol; 2021 Apr; 31(4):2507-2517. PubMed ID: 33033862
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prediction of Hepatocellular Carcinoma by Liver Stiffness Measurements Using Magnetic Resonance Elastography After Eradicating Hepatitis C Virus.
    Kumada T; Toyoda H; Yasuda S; Sone Y; Ogawa S; Takeshima K; Tada T; Ito T; Sumida Y; Tanaka J
    Clin Transl Gastroenterol; 2021 Apr; 12(4):e00337. PubMed ID: 33888672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatic stiffness measurement by using MR elastography: prognostic values after hepatic resection for hepatocellular carcinoma.
    Lee DH; Lee JM; Yi NJ; Lee KW; Suh KS; Lee JH; Lee KB; Han JK
    Eur Radiol; 2017 Apr; 27(4):1713-1721. PubMed ID: 27456966
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liver stiffness measured by magnetic resonance elastography as a risk factor for hepatocellular carcinoma: a preliminary case-control study.
    Motosugi U; Ichikawa T; Koshiishi T; Sano K; Morisaka H; Ichikawa S; Enomoto N; Matsuda M; Fujii H; Araki T
    Eur Radiol; 2013 Jan; 23(1):156-62. PubMed ID: 22814828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Usefulness of MR elastography for detecting clinical progression of cirrhosis from child-pugh class A to B in patients with type C viral hepatitis.
    Takamura T; Motosugi U; Ichikawa S; Sano K; Morisaka H; Ichikawa T; Enomoto N; Onishi H
    J Magn Reson Imaging; 2016 Sep; 44(3):715-22. PubMed ID: 26929192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Value of MR elastography for the preoperative estimation of liver regeneration capacity in patients with hepatocellular carcinoma.
    Jang S; Lee JM; Lee DH; Joo I; Yoon JH; Chang W; Han JK
    J Magn Reson Imaging; 2017 Jun; 45(6):1627-1636. PubMed ID: 27859840
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluating the risk of hepatocellular carcinoma in patients with prominently elevated liver stiffness measurements by FibroScan: a multicentre study.
    Adler M; Larocca L; Trovato FM; Marcinkowski H; Pasha Y; Taylor-Robinson SD
    HPB (Oxford); 2016 Aug; 18(8):678-83. PubMed ID: 27485062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunotherapy response evaluation with magnetic resonance elastography (MRE) in advanced HCC.
    Qayyum A; Hwang KP; Stafford J; Verma A; Maru DM; Sandesh S; Sun J; Pestana RC; Avritscher R; Hassan MM; Amin H; Rashid A; Wistuba II; Ehman RL; Ma J; Kaseb AO
    J Immunother Cancer; 2019 Nov; 7(1):329. PubMed ID: 31779702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Magnetic Resonance Elastography: A Novel Technique for the Detection of Hepatic Fibrosis and Hepatocellular Carcinoma After the Fontan Operation.
    Poterucha JT; Johnson JN; Qureshi MY; O'Leary PW; Kamath PS; Lennon RJ; Bonnichsen CR; Young PM; Venkatesh SK; Ehman RL; Gupta S; Smyrk TC; Dearani JA; Warnes CA; Cetta F
    Mayo Clin Proc; 2015 Jul; 90(7):882-94. PubMed ID: 26059757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Magnetic resonance elastography as a preoperative assessment for predicting intrahepatic recurrence in patients with hepatocellular carcinoma.
    Lee JH; Hwang JA; Gu K; Shin J; Han S; Kim YK
    Magn Reson Imaging; 2024 Jun; 109():127-133. PubMed ID: 38513784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MR elastography of hepatocellular carcinoma: Correlation of tumor stiffness with histopathology features-Preliminary findings.
    Thompson SM; Wang J; Chandan VS; Glaser KJ; Roberts LR; Ehman RL; Venkatesh SK
    Magn Reson Imaging; 2017 Apr; 37():41-45. PubMed ID: 27845245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Longitudinal association of magnetic resonance elastography-associated liver stiffness with complications and mortality.
    Higuchi M; Tamaki N; Kurosaki M; Inada K; Kirino S; Yamashita K; Hayakawa Y; Osawa L; Takaura K; Maeyashiki C; Kaneko S; Yasui Y; Takahashi Y; Tsuchiya K; Nakanishi H; Itakura J; Loomba R; Enomoto N; Izumi N
    Aliment Pharmacol Ther; 2022 Feb; 55(3):292-301. PubMed ID: 34927277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liver stiffness measurement by magnetic resonance elastography is not associated with developing hepatocellular carcinoma in subjects with compensated cirrhosis.
    Anaparthy R; Talwalkar JA; Yin M; Roberts LR; Fidler JL; Ehman RL
    Aliment Pharmacol Ther; 2011 Jul; 34(1):83-91. PubMed ID: 21535445
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subcirrhotic liver stiffness by FibroScan correlates with lower risk of hepatocellular carcinoma in patients with HBV-related cirrhosis.
    Jeon MY; Lee HW; Kim SU; Heo JY; Han S; Kim BK; Park JY; Kim DY; Ahn SH; Han KH
    Hepatol Int; 2017 May; 11(3):268-276. PubMed ID: 28224351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MRI-based risk factors of hepatocellular carcinoma in patients with chronic liver disease: A prospective observational study.
    Shimizu T; Motosugi U; Komatsu N; Ichikawa S; Inoue T; Onishi H; Enomoto N
    J Magn Reson Imaging; 2020 Feb; 51(2):389-396. PubMed ID: 31120640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 3D MR Elastography of Hepatocellular Carcinomas as a Potential Biomarker for Predicting Tumor Recurrence.
    Wang J; Shan Q; Liu Y; Yang H; Kuang S; He B; Zhang Y; Chen J; Zhang T; Glaser KJ; Zhu C; Chen J; Yin M; Venkatesh SK; Ehman RL
    J Magn Reson Imaging; 2019 Mar; 49(3):719-730. PubMed ID: 30260529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.